Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer
Matinas BioPharma has appointed Jerome D. Jabbour, Co-founder and President of Matinas, as its Chief Executive Officer (“CEO”) and a…
Pharmaceuticals, Biotechnology and Life Sciences
Matinas BioPharma has appointed Jerome D. Jabbour, Co-founder and President of Matinas, as its Chief Executive Officer (“CEO”) and a…
Johnson & Johnson has received a binding offer from Platinum Equity, a private investment firm, to acquire its LifeScan business…
Joe Wiley, CEO of Amryt, said Amryt has an ambitious plans for the remainder of 2018 as it looks forward to…
Midatech said its CEO, Dr Jim Phillips will step down at the end of May 2018 after five years, and he…
FDA has fast tracked Destiny Pharma’s lead clinical candidate exeporfinium chloride (XF-73) for the prevention of post-surgical staphylococcal infections such…
Creso Pharma will introduce the cannaDOL product range with an oral Cannabidiol-(CBD)-based nutraceutical and first-in-class CBD-based functional cosmetics across Europe…
Hikma Pharmaceutical has delivered a solid performance in 2017 showing the benefit of our diversified business model, Said Darwazah, Executive Chairman…
A Phase 1 trial of Actimab-A in combination with CLAG-M for relapsed or refractory Acute Myeloid Leukemia (AML) patients, will be…
Pacific Biosciences of California has patented its methods for single molecule sequencing of concatemers having complementary sense and antisense regions…
Vortex BioSciences and Israeli provider of automated cell imaging and analysis solutions, BioView , will work on collecting intact circulating tumour cells…